A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom
- Status
- COMPLETED
- Phase
- N/A
Related studies linked through entity extraction aliases.